Leanna Levine,
Founder & CEO,
ALine, Inc.
Dr. Levine, founder of ALine, Inc., is an entrepreneur, technologist, and inventor. She has a unique blend of technical expertise in both bioanalytical science and manufacturing process development. Prior to founding ALine, Dr. Levine developed bioanalytical technology to support life science research. While at Monsanto, her lab led the industry in the application of fluorescence polarization for high throughput screening for novel therapeutics. In 1998 she joined Spectrum Laboratories as Director of Hollow Fiber Manufacture and Product Development. Dr. Levine earned her Ph.D. at Washington University, St. Louis, MO , and her B.S. in Biochemistry and BA in German from the University of Missouri, Columbia, MO. In 2003 she was a visiting scholar at the UCLA Anderson School of Business. In 2000 she was the chair of the Gordon Conference on Bioanalytical Sensors. She is the co-author on a dozen publications, and several patents.
|
|
Engineered Microfluidic Components for System Integration: Case Studies and Lessons learnedWednesday, 3 October 2018 at 11:00  Add to Calendar ▼2018-10-01 13:45:002018-10-01 14:45:00Europe/LondonSELECTBIOenquiries@selectbiosciences.comMoving quickly from a design to a working benchtop system allows product developers to optimize the analytical triad in microfluidic product development: Cartridge + Instrument + Reagent workflow. In this presentation we provide an overview of our strategies for multi-step assay implementation in a microfluidic platform within 12 weeks, using examples from case studies and highlighting the key lessons learned during the development program.
|
